SmartTab is developing an advanced platform of ingestible capsules to deliver biologics and targeted medications, offering pharmaceutical companies improved product efficacy, novel administration routes, and patent extension opportunities. The SmartTab platform delivers the correct dosages at the appropriate time to targeted locations in the gastrointestinal tract and is intended to replace both traditional coated capsules and injections. SmartTab has completed proof-of-concept pre-clinical studies and is in the process of submitting to the FDA through the 510(k)process.
Robert (Bob) Niichel, Founder/CEO - firstname.lastname@example.org
Sacha Francois Heppell, Chief Marketing Officer - email@example.com